Corridor Capital Acquires Controlling Interest in Create & Cultivate

Cresco Labs Acquires Cultivate in Massachusetts

September 3, 2021

Retail

Cresco Labs has closed its acquisition of Cultivate, a vertically integrated Massachusetts cannabis operator with three dispensaries and approximately 42,000 square feet of active cultivation canopy. The deal increases Cresco's in-state cultivation to ~64,000 square feet and expands its retail footprint in Massachusetts as part of a strategy to deepen presence in large, attractive state markets.

Corridor Capital Invests in Association Headquarters

January 8, 2024

Professional Services

Corridor Capital announced an investment in Association Headquarters, a New Jersey-based association management company, to support the firm's expansion, service development, and pursuit of strategic acquisitions. Management (including President & CEO Bob Waller, Jr. and Chief Executive Relationship Officer Mike Dwyer) will remain in place and retain material ownership.

CULTA Acquires Greenhouse Wellness and Kannavis Dispensaries in Maryland

June 12, 2023

Retail

CULTA, through its subsidiary CULTA Dispensary Group, signed a definitive agreement to acquire two female‑owned Maryland dispensaries: Growing Ventures (d/b/a Greenhouse Wellness) and K&R Holdings (d/b/a Kannavis). The purchases expand CULTA's retail footprint ahead of Maryland's adult‑use legalization and aim to preserve local staff and emphasize product quality and patient experience.

Perceptyx Acquires AI Coaching Platform Cultivate

February 15, 2022

Cloud & SaaS

Perceptyx, the employee listening and people analytics platform, has acquired Cultivate, an AI-powered digital leadership coaching company based in San Francisco. The acquisition integrates Cultivate’s passive listening and hyper-personalized coaching capabilities into Perceptyx’s active listening platform to expand leadership development and action-oriented capabilities for enterprise customers.

ClinActiv Holdings to Acquire Crescita Therapeutics

March 16, 2026

Healthcare Services

Crescita Therapeutics entered into a definitive arrangement agreement to be acquired by ClinActiv Holdings in an all-cash deal valued at $0.80 per share (minimum $0.75), subject to customary working capital adjustments. The transaction is expected to close in Q2 2026 via a court-approved statutory plan of arrangement in Ontario, with Crescita’s shares to be delisted after completion.

Corridor Capital and True West Capital Invest in CEO Warrior

December 23, 2020

Professional Services

Corridor Capital has made a platform investment in CEO Warrior, a New Jersey–headquartered provider of subscription-based business training and implementation services for contractor services businesses, in partnership with the company’s management. True West Capital Partners also participated alongside Corridor, with Comerica Bank providing a senior credit facility to support the transaction; management founders Michael Agugliaro and Robert Zadotti remain material owners and will continue in leadership roles.